차광렬

All filings by 차광렬 on record concern 차바이오텍, in the capacity of chief executive. In total, 67 filings cover trades dated from 18 February 2021 to 14 September 2026.

The open-market side counts 2 purchases alongside 11 sales for €965k. The totals do not cover 9 filings with an undisclosed amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. So far in 2026, the count stands at no purchases and 6 sales.

The latest filing, published on 14 September 2026, reports a transaction in 차바이오텍. The latest purchase dates back some time: it was published 537 days ago, on 29 April 2025. The median gap between a trade and its publication by DART (FSS) is 6 days. This delay matters because a trade only becomes useful information once it is public. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.